News

2018

company

year

domain

Is Boston Biotech in a Bubble?

Flagship Pioneering 03.20.2018

Quanterix Corporation and DestiNA Genomics to Collaborate in Effort to Transform microRNA Biomarker Detection

03.20.2018

Indigo Receives First Organic Certification for Microbial Seed Treatment

Indigo Agriculture 03.20.2018

Denali Therapeutics Announces First-In-Human Dosing Of Its RIPK1 Inhibitor Clinical Program And The Appointment Of Peter Klein To Board Of Directors; Reports Fourth Quarter And Full Year 2017 Financial Results And Business Highlights

Denali Therapeutics 03.19.2018

Indigo Appoints Ann Simonds, Consumer Goods Industry Veteran, to Board of Directors

Indigo Agriculture 03.15.2018

Flagship Pioneering Launches Foghorn Therapeutics With Initial Capital Commitment of $50 Million

Foghorn Therapeutics, Flagship Pioneering 03.14.2018

Torque Appoints John Hohneker, MD, to Board of Directors and Marcela Maus, MD, PhD, to Scientific Advisory Board

03.14.2018

TARIS® Initiates Dosing of TAR-200 (GemRIS™) in Muscle-Invasive Bladder Cancer Patients Unfit for Curative Intent Therapy

03.14.2018

32-Year-Old Professor Raises $50 Million To Make Drugs To Control Genes

Foghorn Therapeutics 03.13.2018

Indigo Cotton™ Demonstrates Continuous Improvement with Significant Yield Gains in Second Commercial Season

Indigo Agriculture 03.13.2018

Loading